Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

1631 ET – Medical device maker Fisher & Paykel Healthcare’s share price rises 4.8% to erase all of this month’s losses as investors cheer an upgrade to its annual profit guidance. F&P Healthcare now expects FY 2026 net profit to total NZ$410 million-NZ$460 million, up from an earlier projection for NZ$390 million-A$440 million. It also signaled higher annual revenue of NZ$2.17 billion-NZ$2.27 billion. Jefferies analyst Vanessa Thomson says ongoing clinical changes, new products and business efficiencies drove the upgrade. Jefferies rates F&P Healthcare a buy, with a NZ$44.40/share price target. F&P Healthcare rose to NZ$38.45 in the first half hour of Wednesday’s trading. (david.winning@wsj.com; @dwinningWSJ)

Health Care Roundup: Market Talk

Tags: